Internal Medicine


Bariatric Surgery Could Cut Risk of Adverse Liver, Cardiovascular Outcomes in NASH

November 22, 2021

An analysis of data from the SPLENDOR study suggests 88% reduction in risk of progression of fatty liver to cirrhosis, liver cancer, or liver-related death and a 70% reduction in risk of major adverse cardiovascular events in patients with NASH and obesity.

AHA 2021: Top Data Slideshow

November 17, 2021

Every year, AHA Scientific Sessions provides clinicians and researchers with a glimpse into the latest data from clinical trials. Our editorial staff's top picks for late-breaking data from AHA 2021 Scientific Sessions includes AVATAR, RAPID CABG, REVERSE-IT, and more.